Category Archives: Aging

Anti-inflammatory utility of Boswellia serrata (frankincense)

Posted on July 27, 2012 by Maurice Preter MD

Reading up on Boswellia serrata – this is a good starter article: http://www.altmedrev.com/publications/13/2/165.pdf “Boswellia serrata Description Boswellia serrata (frankincense) is a moderate-to-large branching tree (growing to a height of 12 feet) found in India, Northern Africa, and the Middle East. … Continue reading →

Posted in Aging, Health, new treatments | Tagged Depression, healthy brain aging, Inflammation, Memory and Memory Loss, Pain and Headache, Traumatic Brain Injury |

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Posted on July 24, 2012 by Maurice Preter MD

================================================ Nutr Metab (Lond). 2009 Aug 10;6:31. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Source Accera, … Continue reading →

Posted in Aging, dietary, Health, metabolic, News, Psychiatry/Neurology | Tagged healthy brain aging, Memory and Memory Loss, Traumatic Brain Injury |

Anxiety, depression with glaucoma. Is isolation/loneliness the link?

Posted on July 21, 2012 by Maurice Preter MD

Psychol Rep. 2010 Apr;106(2):343-57. Anxiety, depression, and quality of life in Turkish patients with glaucoma. Tastan S, Iyigun E, Bayer A, Acikel C. Source School of Nursing, Gülhane Military Medical Academy, Ankara, Turkey. Abstract The purpose was to investigate the … Continue reading →

Posted in Aging, epigenetics, Health, Psychiatry/Neurology | Tagged Depression, Inflammation, separation anxiety |

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.

Posted on March 3, 2012 by Maurice Preter MD

Nutr J. 2011 Oct 20;10:117. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. … Continue reading →

Posted in Aging, Health, metabolic, new treatments | Tagged healthy brain aging, Inflammation, Memory and Memory Loss |

Inflammation and depression: why poststroke depression may be the norm and not the exception.

Posted on March 3, 2012 by Maurice Preter MD

Int J Stroke. 2011 Apr;6(2):128-35. doi: 10.1111/j.1747-4949.2010.00565.x. Epub 2011 Jan 19.Inflammation and depression: why poststroke depression may be the norm and not the exception.Pascoe MC, Crewther SG, Carey LM, Crewther DP.Source Brain Sciences Institute, Swinburne University, Melbourne, Vic, Australia.Abstract Ischaemic … Continue reading →

Posted in Aging | Tagged Depression, Inflammation |

Category Archives: Aging

Anti-inflammatory utility of Boswellia serrata (frankincense)

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Anxiety, depression with glaucoma. Is isolation/loneliness the link?

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.

Inflammation and depression: why poststroke depression may be the norm and not the exception.

Maurice Preter, MD

QUICK LINKS

ADDRESS